NLP

Opioid-exposed infant clinical indicators

Objective 

We leveraged existing data from a single electronic health care system in the southeastern United States to demonstrate the feasibility of measuring quality indicators for the hospital-based care of opioid-exposed newborns using existing data infrastructure. Additionally, we identified other key variables related to the care of opioid-exposed maternal-infant dyads.   

Patients and Methods 

Owner Phenotyping Groups: 
Vanderbilt University Medical Center - Wei Lab
View Phenotyping Groups: 
Vanderbilt University Medical Center - Wei Lab
Final

SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria

Systemic Lupus Erythematosus (SLE) is a chronic, systemic autoimmune disease that can affect many parts of the body including skin, lungs, brain, heart, kidneys, joints, and blood vessels. SLE presentation can vary significantly between patients. Because of this, it can be challenging to identify a patient as having SLE. Between 300,000 and 2,000,000 people in the US are estimated to have SLE. Determination of an exact number of people affected is challenging as the disease is difficult to identify given the diverse presentations and the length of time it may take for symptoms to appear.

Owner Phenotyping Groups: 
eMERGE Northwestern Group
View Phenotyping Groups: 
eMERGE Mayo Group
eMERGE Phenotype WG
Final